Sun Pharma sees Ilumya recovery, Organon on track
Sun Pharmaceutical Industries expects sales of its psoriasis drug Ilumya in the US to improve over the coming months, after the September 2026 quarter faced headwinds from purchasing decisions and pricing pressures.…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.